建立并验证评分系统预测食管鳞癌(cT1-3N0M0)喉返神经淋巴结转移.pdf

建立并验证评分系统预测食管鳞癌(cT1-3N0M0)喉返神经淋巴结转移.pdf

  1. 1、本文档共23页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
福建医科大学硕士学位论文 Development and Validation of Scoring System for Predicting Recurrent Laryngeal Nerve Lymph Node Metastases in Clinical Stage T1-3N0M0 Esophageal Squamous Cell Carcinoma Abstract Objectives: Recurrent laryngeal nerve lymph node (RLN LN) dissection is difficult for esophageal squamous cell carcinoma (ESCC) and usually causes recurrent laryngeal nerve injury. This study aims to develop a simple scoring system to predict RLN LN metastases in clinical stage T1-3N0M0 ESCC and explore indications for selective RLN LN dissection. Methods: Patients with clinical stage T1-3N0M0 ESCC at the Fujian Medical University Union Hospital from January 2010 to December 2014 were analyzed. Patients were divided into modeling group and validation group. Patient and pathologic characteristics were compared between patients in modeling group with RLN LN metastases and those without. Univariate and multivariate analyses were performed to establish a scoring system that estimates risk for RLN LN metastases. The scoring system is developing by weighing beta coefficient of the final model. The final model performance is evaluated by the area under the ROC curve of model group and validation group. Patients were divided into low-risk, moderate-risk and high-risk groups according to the scoring system and the indications for RLN LN dissection in various groups were validated by RLN LN metastases rate, survival rate, QOL and complications. Results: A total of 218 cases selected from 974 ESCC patients were included for analysis and randomly divided into 9 groups including 169 patients (7 groups) in modelling group and 49 patients (2 groups) in validation group. Th

您可能关注的文档

文档评论(0)

5566www + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:6122115144000002

1亿VIP精品文档

相关文档